Skip to content
Medical Health Aged Care

Second Voluntary Assisted Dying Conference opens in Brisbane

Go Gentle Australia 2 mins read

Brisbane, 28 October 2024 – Removing barriers to voluntary assisted dying for eligible terminally ill people is the focus of the second trans-Tasman Voluntary Assisted Dying Conference (VADCON24) in Brisbane this week.

Voluntary assisted dying (VAD) is legal in all six Australian states, the ACT and New Zealand and is increasingly accepted in healthcare settings; however, challenges remain to ensure all eligible people who want the choice are able to use it.

Hosted by VADANZ (the peak body representing VAD practitioners), the Australian Centre for Health Law Research (ACHLR) and Go Gentle Australia, more than 400 delegates will hear from experts on how to improve service delivery.

"People seeking choice at the end of life are facing unnecessary barriers, chief among them a lack of awareness that VAD is a legal and available choice, as well as complex VAD application processes. They also may need to contend with uncooperative healthcare facilities,” Go Gentle Australia’s CEO, Dr Linda Swan, said.

“In addition, the legal prohibitions in some jurisdictions on initiating discussions about VAD and the Australian prohibition on using electronic communications such as telehealth, mean many eligible people, especially those in rural and regional areas, struggle to find the help they need.

“We must find ways to remove these obstacles and encourage more health professionals to do the VAD training so every terminally ill person gets the high-quality care they deserve,” Dr Swan said.

Among the speakers:

  • Dr Rob Grenfell, chief of strategy and regions, Grampians Health on Reimagining the way we die, designing future-focused, integrated health and wellbeing systems
  • Representatives from VAD oversight bodies in each jurisdiction
  • Andrew Denton, in discussion with an expert panel on VAD and institutions: How to allow conscientious objection and avoid obstruction?
  • Broadcaster Hamish Macdonald chairing expert panel discussions on Time frames in VAD: Safeguards or barriers? and Loss of decision-making capacity and VAD.
  • Dr Linda Swan, GGA CEO, Future-proofing the VAD workforce.

The conference follows the release of the first Australian and New Zealand analysis of official data that shows VAD laws are working safely and as intended, and fulfilling their dual aims to offer terminally ill people choice and relieve suffering.

“Along with areas for improvement, there are many examples of collaboration and high-quality care to be celebrated. The conference will explore how these successes can be shared and amplified.

“We are thrilled this year to partner with QUT’s Australian Centre for Health Law Research to add a stronger academic component. We are also excited to host a gala dinner and awards ceremony to honour community champions and innovators in the fields of VAD research, clinical care and advocacy,” Dr Swan said.

What: Second Trans-Tasman Voluntary Assisted Dying Conference

When: Monday 28 October to Tuesday 29 October 2024, 8am -5pm

Where: QUT Gardens Point Campus: Level 4, Z Block, Lamington Drive, Brisbane

Details: https://www.gogentleaustralia.org.au/vadcon24_conf_program

Media contact: For media passes and interviews with conference speakers contact 0426 283 865   media@gogentleaustralia.org.au


Key Facts:

VAD laws have been passed in all six Australian states, the ACT and New Zealand

They are working safely and as intended

Awareness of and demand for VAD are growing

Restricting healthcare professionals' conversations about VAD is impeding access

Procedural elements, some intended as safeguards, are working as obstacles to access

Workloads and remuneration remain serious issues - sustainablity of VAD services is uncertain 


Contact details:

Media contact: For media passes and interviews with conference speakers contact 0426 283 865   media@gogentleaustralia.org.au

Media

More from this category

  • Government NSW, Medical Health Aged Care
  • 27/10/2024
  • 07:35
Uniting NSW.ACT

Strong support for health and welfare responses for minor drug possession says two-thirds of NSW voters

As the countdown begins towards the first highly anticipated Drug Summit in Griffith, new uComms polling, commissioned by Uniting NSW.ACT, is showing 66 per cent of voters in key NSW seats support a health and welfare response to minor drug possession. Thousands of voters across five key metropolitan and regional NSW electorates (Kogarah, Bankstown, Penrith, Lismore, Tamworth) were surveyed. The polling shows voters would prefer to see warnings issued, or referrals to treatment or drug education programs rather than sending people to court when they’re found with small quantities of illicit drugs such as ecstasy, heroin and methamphetamine. There was…

  • Medical Health Aged Care
  • 26/10/2024
  • 01:10
Rigaku Holdings Corporation

Listing on the Tokyo Stock Exchange Prime Market

TOKYO--BUSINESS WIRE-- Rigaku Holdings Corporation, a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; "Rigaku"), has completed its listing on the Tokyo Stock Exchange Prime Market as of today. Note: This document is a press release intended for public announcement regarding Rigaku's listing on the Tokyo Stock Exchange Prime Market. It has not been prepared for the purpose of soliciting investments or any similar acts, whether within or outside Japan. This press release does not constitute an offer or sale of securities in the United States. The shares of common stock of Rigaku may…

  • Medical Health Aged Care
  • 25/10/2024
  • 16:11
Galderma

Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends

Galderma convenes a new edition of the Galderma Aesthetic Injector Network (GAIN) event in the Asia-Pacific region (JPAC), which will be the largest to…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.